SSCI Investigator Recognized as the 2017 Williams-Wright Award Winner by the Coblentz Society

Share Article

Formal presentation will take place at the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (PITTCON) on Wednesday, March 8, 2017.

News Image
We are proud of Slobodan’s achievements to advance the understanding of these essential analytical tools to meet a diverse array of pharmaceutical applications.”

The Coblentz Society has recognized Dr. Slobodan Sasic with the 2017 Williams-Wright Award for his significant contributions to vibrational spectroscopy. Dr. Sasic will receive this recognition at the Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy (PITTCON) on Wednesday, March 8, 2017.

In his current role as Senior Research Investigator at SSCI, AMRI’s Center of Excellence for Solid State Chemistry, Dr. Sasic is applying vibrational spectroscopy, chemical imaging, X-ray powder diffraction, and chemometrics for analysis and development of validated methods for pharmaceutical solid forms.

“This award annually recognizes spectroscopists who have made significant impact to industry,” commented David A. Engers, PhD, Senior Director and Site Head at SSCI. “As the industry leader in solid state and analytical chemistry services, we are proud of Slobodan’s achievements to advance the understanding of these essential analytical tools to meet a diverse array of pharmaceutical applications.”

Dr. Sasic obtained his doctorate from the University of Belgrade in Serbia. His post-doctoral roles included Kwansei-Gakuin University (Japan) in various applications of vibrational spectroscopy, chemometrics, 2D correlation spectroscopy, and surface-enhanced Raman spectroscopy (SERS), and Massachusetts Institute of Technology (MIT) on a method for non-invasive analysis of glucose based on Raman spectroscopy and multivariate calibration. Before joining SSCI, he worked at Pfizer, Inc. and later Vertex Pharmaceuticals specializing in vibrational spectroscopy-based chemical imaging of pharmaceuticals, and using NIR spectroscopy for in-process monitoring of pharmaceutical materials.

About SSCI
SSCI, a division of Albany Molecular Research Inc., provides industry leading contract solid-state and analytical testing services and exists to help companies in the pharmaceutical, food, agrochemical, and other chemical industries develop better products and get them to market more quickly. Over the past quarter century, SSCI has provided comprehensive cGMP research and analytical services in the characterization and chemistry of solid materials, with particular expertise in small and large molecules being investigated for pharmaceutical use. As the AMRI’s Center of Excellence for Solid State Chemistry, its offerings include early candidate support services (in vitro analysis, stability, solubility, dissolution, excipient compatibility), solid form screening and polymorph, salt and cocrystal screening, form selection, particle engineering (process development, particle size method development), property improvement, crystallization of difficult materials, process control, biochemical analysis, full analytical chemistry support including method development and validation, intellectual property consulting and litigation support, and related research activities.

For more information about SSCI’s solid-state and analytical chemistry services, please contact 1-800-375-2179 | http://www.ssci-inc.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

David Engers
SSCI
+1 765-463-0112
Email >
SSCI (Solid State Chemical Information)

Follow us on
Visit website